Outlook Therapeutics, Inc. (OTLK) Social Stream
Outlook Therapeutics Inc (OTLK) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering OTLK.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 50 weeks, OTLK's average price target has gone up $2.37.
OTLK reports an average of 184.92% for its upside potential over the past 50 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
OTLK Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for OTLK as an investment opportunity.
- OTLK has a higher upside potential (average analyst target price relative to current price) than 97.12% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Outlook Therapeutics Inc's number of analysts covering the stock is higher than 5.5% of them.
- Outlook Therapeutics Inc's average analyst price target is greater than 11.05% of Healthcare stocks.
- Outlook Therapeutics Inc's variance in analysts' estimates is lower than 73.34% of Pharmaceutical Products stocks.
Is OTLK a Buy, Hold or Sell? See the POWR Ratings now!